Search research articles
Contact Us
Filters
Showing results (311-320 of 476) with videos related to
Page
of 48
Sort By:
JCO Precision Oncology
|
September 4, 2025
Real-World Validation of the Purity Independent Subtyping of Tumors Classifier for Informing Therapy Selection in Pancreatic Ductal Adenocarcinoma
Stephane Wenric, Chithra Sangli, John Guittar, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 13, 2001
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
T Sørlie, C M Perou, R Tibshirani, et al.
Science Advances
|
September 27, 2024
Estrogen signaling suppresses tumor-associated tissue eosinophilia to promote breast tumor growth
Sandeep Artham, Patrick K Juras, Aditi Goyal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 13, 2023
Integrated Multimodal Analyses of DNA Damage Response and Immune Markers as Predictors of Response in Metastatic Triple-Negative Breast Cancer in the TNT Trial (NCT00532727)
Holly Tovey, Orsolya Sipos, Joel S Parker, et al.
Nano Letters
|
December 15, 2016
Docetaxel-Loaded PLGA Nanoparticles Improve Efficacy in Taxane-Resistant Triple-Negative Breast Cancer
Charles J Bowerman, James D Byrne, Kevin S Chu, et al.
Cell Reports
|
July 14, 2015
Wild-Type N-Ras, Overexpressed in Basal-like Breast Cancer, Promotes Tumor Formation by Inducing IL-8 Secretion via JAK2 Activation
Ze-Yi Zheng, Lin Tian, Wen Bu, et al.
Nature
|
April 10, 2015
A model of breast cancer heterogeneity reveals vascular mimicry as a driver of metastasis
Elvin Wagenblast, Mar Soto, Sara Gutiérrez-Ángel, et al.
Ebiomedicine
|
November 14, 2022
HER2DX genomic test in HER2-positive/hormone receptor-positive breast cancer treated with neoadjuvant trastuzumab and pertuzumab: A correlative analysis from the PerELISA trial
Valentina Guarneri, Fara Bras-Maristany, Maria Vittoria Dieci, et al.
The Journal of Clinical Investigation
|
August 16, 2021
Entinostat induces antitumor immune responses through immune editing of tumor neoantigens
Andrew S Truong, Mi Zhou, Bhavani Krishnan, et al.
BMC Medical Genomics
|
August 23, 2015
Development and verification of the PAM50-based Prosigna breast cancer gene signature assay
Brett Wallden, James Storhoff, Torsten Nielsen, et al.
Page
of 48
Search research articles
Search
Showing results (311-320 of 476) with videos related to
Sort By:
Page
of 48
JCO Precision Oncology
|
September 4, 2025
Real-World Validation of the Purity Independent Subtyping of Tumors Classifier for Informing Therapy Selection in Pancreatic Ductal Adenocarcinoma
Stephane Wenric, Chithra Sangli, John Guittar, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 13, 2001
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
T Sørlie, C M Perou, R Tibshirani, et al.
Science Advances
|
September 27, 2024
Estrogen signaling suppresses tumor-associated tissue eosinophilia to promote breast tumor growth
Sandeep Artham, Patrick K Juras, Aditi Goyal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 13, 2023
Integrated Multimodal Analyses of DNA Damage Response and Immune Markers as Predictors of Response in Metastatic Triple-Negative Breast Cancer in the TNT Trial (NCT00532727)
Holly Tovey, Orsolya Sipos, Joel S Parker, et al.
Nano Letters
|
December 15, 2016
Docetaxel-Loaded PLGA Nanoparticles Improve Efficacy in Taxane-Resistant Triple-Negative Breast Cancer
Charles J Bowerman, James D Byrne, Kevin S Chu, et al.
Cell Reports
|
July 14, 2015
Wild-Type N-Ras, Overexpressed in Basal-like Breast Cancer, Promotes Tumor Formation by Inducing IL-8 Secretion via JAK2 Activation
Ze-Yi Zheng, Lin Tian, Wen Bu, et al.
Nature
|
April 10, 2015
A model of breast cancer heterogeneity reveals vascular mimicry as a driver of metastasis
Elvin Wagenblast, Mar Soto, Sara Gutiérrez-Ángel, et al.
Ebiomedicine
|
November 14, 2022
HER2DX genomic test in HER2-positive/hormone receptor-positive breast cancer treated with neoadjuvant trastuzumab and pertuzumab: A correlative analysis from the PerELISA trial
Valentina Guarneri, Fara Bras-Maristany, Maria Vittoria Dieci, et al.
The Journal of Clinical Investigation
|
August 16, 2021
Entinostat induces antitumor immune responses through immune editing of tumor neoantigens
Andrew S Truong, Mi Zhou, Bhavani Krishnan, et al.
BMC Medical Genomics
|
August 23, 2015
Development and verification of the PAM50-based Prosigna breast cancer gene signature assay
Brett Wallden, James Storhoff, Torsten Nielsen, et al.
Page
of 48